About Canexia
Together, we’re making precision oncology accessible

At Canexia Health, we empower our partners with end-to-end solutions that allow you to deploy cancer genomic tests within your own facility.

About Us
Solutions
Helping you deliver precision care

Canexia Health makes high-quality cancer genomic information accessible and affordable with our clinically-validated assays, informatics, and support.

About Our Solutions
- Find It^®
  
  Detect mutations in solid tumor tissue
  
  Tailor treatment decisions based on somatic mutations in your patient’s tumor.
  
  About Find It
- Follow It^®
  
  Detect mutations in plasma
  
  A minimally invasive assay for biopsy, Follow It can also be used to monitor cancer progression or detect treatment resistance.
  
  About Follow It
- Fusions
  
  Detect known and novel fusions in solid tumors
  
  Rapid, cost-effective, and clinically actionable, Fusions allows you the flexibility to isolate and interrogate only relevant fusions.
  
  About Fusions
- Canexia Informatics Platform
- Implementation
Technology
Resources

Webinar

April 15, 2020

Best Practices for Bringing Liquid Biopsy In-house

Facebook0 Tweet0 LinkedIn0

Back

Recent Resources

Press

July 15, 2020

Canadian Consortium Increases Access to Cancer Testing and Treatment in Response to COVID-19

A consortium led by Vancouver-based Canexia Health (formerly Contextual Genomics) will enable access to critical testing and treatment options for Canadian cancer patients during the COVID-19 pandemic.

Blog

July 15, 2020

Project ACTT Announced & New Name for Contextual Genomics

Early this morning we announced an initiative to deliver and enhance a minimally invasive circulating tumor DNA (ctDNA) test to cancer patients across Canada in response to COVID-19.

Blog

June 15, 2020

Pros and Cons of Liquid Biopsy for Cancer Management

Introduction

In the last decade many new targeted therapies have been approved by the FDA.

View All Resources